This document discusses antisense RNA and DNA technology. It explains that antisense works by introducing short DNA or RNA sequences that are complementary to target mRNA, preventing translation into protein. This can inhibit genetic disorders caused by mutated proteins. The document provides examples of using antisense to treat diseases like cancer and viruses. It describes various methods of delivering antisense sequences into cells and notes that while promising, most antisense therapies have yet to produce significant clinical results, though one was approved by the FDA to treat cytomegalovirus retinitis.